跳至主要内容
临床试验/NCT01466465
NCT01466465已完成2 期

Vitamin D and Grass Pollen Specific Immunotherapy

Charite University, Berlin, Germany1 个研究点 分布在 1 个国家目标入组 35 人开始时间: 2011年10月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
状态
已完成
入组人数
35
试验地点
1
主要终点
wheal diameter in the intradermal test after SIT in the comparison between vitamin D and placebo

研究概览

简要总结

Allergen-specific immunotherapy is the only causal therapy of Immunoglobulin E-induced allergies like allergic rhinoconjunctivitis. Despite progress during the last decades it is limited by a long treatment time and high non-responder frequency. Based on experimental and epidemiological evidences we hypothesize that vitamin D can act as an effective immunomodulatory adjuvant to overcome these limitations.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Investigator)

入排标准

年龄范围
18 Years 至 55 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • written informed consent
  • relative Vitamin D deficiency
  • clinical relevant grass pollen allergy
  • positive intradermal test with grass pollen
  • forced expiratory volume at one second (FEV1) > 70%

排除标准

  • current specific immunotherapy
  • instable allergic asthma
  • pregnancy and lactation
  • treatment with immunomodulators or immunosuppressive drugs
  • sarcoidosis, chronic diseases, malignancy

研究组 & 干预措施

Vigantol

Experimental

干预措施: Cholecalciferol (Drug)

neutral oil (vigantol carrier)

Placebo Comparator

干预措施: middle-chain fatty acids (carrier) (Other)

结局指标

主要结局

wheal diameter in the intradermal test after SIT in the comparison between vitamin D and placebo

时间窗: three years

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Margitta Worm

Prof. Dr. med.

Charite University, Berlin, Germany

研究点 (1)

Loading locations...

相似试验